Chan Y C, Morales J P, Reidy J F, Taylor P R
Department of Vascular & Endovascular Surgery, Guy's & St Thomas' NHS Foundation Hospital, St. Thomas' Hospital, London, UK.
Int J Clin Pract. 2008 Oct;62(10):1604-13. doi: 10.1111/j.1742-1241.2007.01494.x. Epub 2007 Oct 19.
Retroperitoneal haematoma is a rare clinical entity with variable aetiology, which is increasing in incidence mainly due to complications related to interventional procedures. There is no general consensus as to the best management plan for patients with retroperitoneal haematoma.
A literature review was undertaken using MEDLINE, all relevant papers on retroperitoneal haemorrhage or haematoma were used.
The diagnosis is often delayed as symptoms are nonspecific. Retroperitoneal haematoma should be suspected in patients with significant groin, flank, abdominal, back pain or haemodynamic instability following an interventional procedure. Spontaneous haemorrhage usually occurs in patients who are anticoagulated. Multi-slice CT and arteriography are important for diagnosis. Most haemodynamically stable patients can be managed with fluid resuscitation, correction of coagulopathy and blood transfusion. Endovascular treatment involving selective intra-arterial embolisation or the deployment of stent-grafts over the punctured vessel is attaining an increasingly important role. Open repair of retroperitoneal bleeding vessels should be reserved for cases when there is failure of conservative or endovascular measures to control the bleeding. Open repair is also required if endovascular facilities or expertise is unavailable and in cases where the patient is unstable. If treated inappropriately, the mortality of patients with retroperitoneal haematoma remains high.
There is a lack of level I evidence for the best management plans for retroperitoneal haematoma, and evidence is based on small cohort series or isolated case reports. Conservative management should only be reserved for patients who are stable. Interventional radiology with intra-arterial embolisation or stent-grafting is the treatment of choice. Open surgery is now rarely required.
腹膜后血肿是一种病因多样的罕见临床病症,其发病率主要因与介入操作相关的并发症而呈上升趋势。对于腹膜后血肿患者的最佳管理方案尚无普遍共识。
使用MEDLINE进行文献综述,纳入所有关于腹膜后出血或血肿的相关论文。
由于症状不具特异性,诊断往往延迟。对于介入操作后出现明显腹股沟、侧腹、腹部、背部疼痛或血流动力学不稳定的患者,应怀疑腹膜后血肿。自发性出血通常发生在接受抗凝治疗的患者中。多层螺旋CT和血管造影对诊断很重要。大多数血流动力学稳定的患者可通过液体复苏、纠正凝血功能障碍和输血进行管理。涉及选择性动脉内栓塞或在穿刺血管上部署覆膜支架的血管内治疗正发挥着越来越重要的作用。腹膜后出血血管的开放修复应保留用于保守或血管内措施无法控制出血的情况。如果没有血管内设备或专业技术,以及患者情况不稳定时,也需要进行开放修复。如果治疗不当,腹膜后血肿患者的死亡率仍然很高。
对于腹膜后血肿的最佳管理方案缺乏一级证据,现有证据基于小队列系列或个别病例报告。保守治疗应仅适用于病情稳定的患者。动脉内栓塞或覆膜支架置入的介入放射学是首选治疗方法。现在很少需要进行开放手术。